Daxdilimab is a human anti-ILT7 monoclonal antibody. Daxdilimab binds to ILT7 on the surface of pDCs, which leads to the depletion of these cells and inhibits inflammation in a variety of autoimmune conditions.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.